The Pacific Treatment & Research In Psychedelics (TRIP) program is dedicated to the development of psychedelic-assisted therapies and the scientific exploration of how altered states of consciousness can be harnessed to change behavior and improve brain health and quality of life.
Behavioral health issues are a leading cause of disability and they remain inadequately treated worldwide. The modest effectiveness of existing treatments such as antidepressants and traditional psychotherapy approaches show us that there is an urgent need for more effective treatments for conditions such as depression, alcoholism, smoking cessation, and end of life suffering.
Early studies of psychedelic-assisted therapies for these conditions have demonstrated much larger and durable effects compared to existing therapies suggesting that there is great potential for psychedelic-assisted treatments to revolutionize the treatment of mental health and behavioral disorders.
For more information: www.pacificneu...
4 окт 2024
